These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and psychoanaleptic properties of new compounds structurally related to diphenhydramine. Buzas A; Champagnac A; Dehnel A; Lavielle G; Pommier M J Med Chem; 1980 Feb; 23(2):149-53. PubMed ID: 6102153 [TBL] [Abstract][Full Text] [Related]
7. [PSYCHOANALEPTIC ACTION OF SOME ANOREXIGENIC PHENYLETHYLAMINE DERIVATIVES]. BOISSIER JR; SIMON P; FICHELLE J; HERVOUET F Therapie; 1965; 20():297-309. PubMed ID: 14326876 [No Abstract] [Full Text] [Related]
8. The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™). Kavanagh P; Angelov D; O'Brien J; Power JD; McDermott SD; Talbot B; Fox J; O'Donnell C; Christie R Drug Test Anal; 2013 Apr; 5(4):247-53. PubMed ID: 22374810 [TBL] [Abstract][Full Text] [Related]
9. Testing drugs for abuse liability and behavioral toxicity: progress report from the laboratories at the Johns Hopkins University School of Medicine. Brady JV; Griffiths RR NIDA Res Monogr; 1983 Apr; 43():99-124. PubMed ID: 6135997 [No Abstract] [Full Text] [Related]
10. [Appetite depressants, new method for synthesis of 2-amino-2-oxazoline derivatives]. Belzecki C; Peksa S Acta Pol Pharm; 1971; 28(2):151-5. PubMed ID: 5092575 [No Abstract] [Full Text] [Related]
11. Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane. Kumar Y; Florvall L; Ask AL; Ross SB; Holm AC; Ogren SO Acta Pharm Suec; 1983; 20(5):349-64. PubMed ID: 6666598 [No Abstract] [Full Text] [Related]
12. Synthesis of tetrahydronaphthyl thioureas as potent appetite suppressants. Bhandari K; Srivastava S; Shankar G Bioorg Med Chem; 2004 Aug; 12(15):4189-96. PubMed ID: 15246095 [TBL] [Abstract][Full Text] [Related]
13. Specifically deuterated 1-phenylisopropylamines. II. Synthesis of deuterium labelled phentermine. Lindeke B; Cho AK; Fedorchuk M Acta Pharm Suec; 1972 Dec; 9(6):605-8. PubMed ID: 4656568 [No Abstract] [Full Text] [Related]
14. [Experimental studies with the new appetite depressant N-(3-chlorpropyl)-1-methyl-2-phenylethylamine hydrochloride (Ro 4-5282)]. Blum JE Arzneimittelforschung; 1969 May; 19(5):748-55. PubMed ID: 5819782 [No Abstract] [Full Text] [Related]
15. Fenfluramine: study of its central action through its effects on sleep. Gagnon MA; Bordeleau JM; Tétreault L Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):74-82. PubMed ID: 4894948 [No Abstract] [Full Text] [Related]
16. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores. Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405 [No Abstract] [Full Text] [Related]
17. Synthesis and CNS activities of some 2-alkyl-3(2-substituted indol-3-yl)-methyl, 6-substituted-quinazolin-4(3H)-ones. Misra S; Satsangi RK; Tiwari SS Pol J Pharmacol Pharm; 1982; 34(5-6):441-7. PubMed ID: 6138761 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic properties of certain derivatives of phenylethylamine and phenylmethane. Patkowski J; Pelczarska A Arch Immunol Ther Exp (Warsz); 1967; 15(1):88-96. PubMed ID: 6048231 [No Abstract] [Full Text] [Related]
19. Synthesis and lack of biological activity of Glu-His-Gly, a proposed anorexogenic peptide. Björkman S; Karlsson JA; Sievertsson H; Lewander T; Bowers CY Acta Pharm Suec; 1980; 17(3):130-6. PubMed ID: 7468233 [No Abstract] [Full Text] [Related]
20. [Derivatives of N-hydroxyfenfluramine and their anorectic activity]. Bianchi M; Butti A; Dragonetti M Farmaco Sci; 1984 Dec; 39(12):1061-72. PubMed ID: 6529986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]